Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa.
about
Recent Advances in Multi-Drug Resistance (MDR) Efflux Pump Inhibitors of Gram-Positive Bacteria S. aureusStructural basis for the inhibition of bacterial multidrug exportersIdentification of natural compound inhibitors for multidrug efflux pumps of Escherichia coli and Pseudomonas aeruginosa using in silico high-throughput virtual screening and in vitro validationEfficacy of Antibacterial Peptides Against Peptide-Resistant MRSA Is Restored by Permeabilization of Bacteria MembranesMolecular epidemiological survey of bacteremia by multidrug resistant Pseudomonas aeruginosa: the relevance of intrinsic resistance mechanisms.Current Advances in Developing Inhibitors of Bacterial Multidrug Efflux PumpsPossible Role of Curcumin as an Efflux Pump Inhibitor in Multi Drug Resistant Clinical Isolates of Pseudomonas aeruginosa.Overexpression of Efflux Pump in Multiresistant Pseudomonas aeruginosa: How You Will Discover and Treat It?New Structural Templates for Clinically Validated and Novel Targets in Antimicrobial Drug Research and Development.Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and PerspectivesAdaptation-based resistance to siderophore-conjugated antibacterial agents by Pseudomonas aeruginosaAssessment of antibiotic resistance in Klebsiella pneumoniae exposed to sequential in vitro antibiotic treatments.An overview of bacterial efflux pumps and computational approaches to study efflux pump inhibitors.1-(1H-indol-3-yl)ethanamine derivatives as potent Staphylococcus aureus NorA efflux pump inhibitors.Efflux as a mechanism of antimicrobial drug resistance in clinical relevant microorganisms: the role of efflux inhibitors.The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAβN) permeabilizes the outer membrane of gram-negative bacteria.Loss of Methyltransferase Function and Increased Efflux Activity Leads to Doxycycline Resistance in Burkholderia pseudomallei.Bifunctional antimicrobial conjugates and hybrid antimicrobials.Spread of Efflux Pump Overexpressing-Mediated Fluoroquinolone Resistance and Multidrug Resistance in Pseudomonas aeruginosa by using an Efflux Pump Inhibitor.Development of an accumulation assay and evaluation of the effects of efflux pump inhibitors on the retention of chlorhexidine digluconate in Pseudomonas aeruginosa and Staphylococcus aureus.Efflux pumps of Mycobacterium tuberculosis play a significant role in antituberculosis activity of potential drug candidates.Drug detoxification dynamics explain the postantibiotic effect.Modulation of the Neisseria gonorrhoeae drug efflux conduit MtrE.Evolution of structural fitness and multifunctional aspects of mycobacterial RND family transporters.Hexafluoroisopropanol mediated benign synthesis of 2H-pyrido[1,2-a]pyrimidin-2-ones by using a domino protocol.Nitrothiophene carboxamides, a novel narrow spectrum antibacterial series: Mechanism of action and Efficacy.Identification of a Novel Polyamine Scaffold With Potent Efflux Pump Inhibition Activity Toward Multi-Drug Resistant Bacterial Pathogens.
P2860
Q26829852-EB9715E0-4CB4-4253-8421-1696CD4024D4Q27685149-D5C9F543-CB14-49B1-BC5C-474FA52D40C8Q28540748-DA78CD18-77C3-45F6-94B6-EFDC066FE91FQ30369318-07D38A41-A511-4A34-87FB-E0A80F2C37E7Q33648133-C2F3C656-5F3A-4FBC-80A0-3F9862EE3894Q33659230-6CE141AD-3A01-41E9-BE88-EA18FB18D581Q34617966-57A55993-D8AF-4ED5-AF0C-36CFA10AA258Q35829634-38979227-B7E5-438D-BABE-77EAB679968CQ36153263-1FCEE8AC-75F1-4A71-B76E-AF80CB216728Q36575916-A60FA9AE-9B6F-4593-8D09-BE0BA9E0A70BQ37123987-B357D6EF-D7EE-4D52-8AB9-47BE60D9519AQ37490975-CAF14C38-90C8-4145-B00D-32C8D4BD7EF5Q38715925-36D7439D-8F64-4577-BB10-55B3254CF42BQ39010675-E18B270E-E63F-4BFA-BA98-F403B8D92AAAQ39021961-3B66F941-018C-40FB-B2D6-392DCC460462Q39358619-038FD072-C6D3-4376-90D0-379F45AFB4FDQ39582866-DD8D598E-CDDF-4B13-A1F2-2A9B9CE67C3DQ40203926-2AC66CA7-65A4-4B45-BCFA-FE21A652B3A5Q41116821-6544C04D-6130-43BF-B502-5AFAD47966D6Q41147162-0A60A9AB-DB96-4928-A378-771DF6010429Q42151604-19F5E7FC-8A7B-459E-9E78-3994C31F79FEQ44932110-1D0CB2D2-4B42-4F0A-8514-4A1B277A08AAQ47126036-CD407F08-0C96-4423-A947-D682B8A7B8C0Q47738368-4167CCFF-BE22-400B-98A5-B6F5C6E32E58Q50073712-72D1CC38-AAAF-4B8A-B160-06B00411CFC9Q54203030-4C1E92DF-2175-4661-B819-91749E0D942BQ55398494-374BE993-79E0-4AAD-8DFC-869180B6A256
P2860
Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa.
@en
Efflux pump inhibitors
@nl
type
label
Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa.
@en
Efflux pump inhibitors
@nl
prefLabel
Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa.
@en
Efflux pump inhibitors
@nl
P2093
P2860
P356
P1476
Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa
@en
P2093
Ibrahim Taher
Momen Askoura
Turki Abujamel
P2860
P356
10.3402/LJM.V6I0.5870
P577
2011-05-13T00:00:00Z